Closure of Small Patent Ductus Arteriosus by Occluding Detachable Coil

Authors

  • A. Shahmohammadi Shaheed Rajaee Cardiovascular Medical Center, Tehran, Iran
  • A. Yazdanparast Bushehr University of Medical Sciences, Bushehr, Iran
  • M. Meraji Shaheed Rajaee Cardiovascular Medical Center, Tehran, Iran
  • MY. Aarabi Shaheed Rajaee Cardiovascular Medical Center, Tehran, Iran
  • P. Nakhostin Davari Shaheed Rajaee Cardiovascular Medical Center, Tehran, Iran
  • S. Mehralizadeh Semnan University of Medical Sciences, Semnan, Iran
Abstract:

This article doesn't have abstract

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

closure of small patent ductus arteriosus by occluding detachable coil

0

full text

Intravenous Paracetamol and Patent Ductus Arteriosus Closure

Background: Standard medical treatments for patent ductus arteriosus (PDA) closure are, including indomethacin/ibuprofen and surgical ligation. Nowadays, a new strategy to close PDA is the use of paracetamol. The present study aimed to describe the use of intravenous (IV) paracetamol for PDA closure in neonates who present a contraindication to ibuprofen or ibuprofen failure with no possibility...

full text

Transfemoral plug closure of patent ductus arteriosus.

A patent ductus arteriosus should be closed because of its hemodynamic significance and/or the risk of infective endocarditis. Mortality of surgery is low. In adults, however, technical problems can arise due to calcification of the ductus walls. Using the transfemoral plug technique, developed by Porstmann, we attempted a ductus closure without surgery on 35 patients. The youngest was an 11-ye...

full text

Transcatheter Closure of Patent Ductus Arteriosus

Background The USCI PDA Umbrella is a device to close patent ductus arteriosus (PDA) by a transcatheter technique. Human clinical trials have shown excellent efficacy in reducing or eliminating the PDA shunt, but concerns remain about the risk of infection with this device. The purpose of this study was to evaluate the risk of infection using an animal model. Methods and Results Susceptibility ...

full text

Transcatheter Closure of Patent Ductus Arteriosus

Patent ductus arteriosus (PDA) constitutes 6 to 11% of all congenital heart defects. While surgical ligation and video-assisted, thoracoscopic interruption of PDA are still available, transcatheter occlusion of PDAs has recently assumed a major role in closure of PDA. A large number of devices have been designed and tested both in animal models and human subjects, but only few devices (free and...

full text

Transcatheter device closure of patent ductus arteriosus.

OBJECTIVE To determine the efficacy, safety and immediate complications encountered during percutaneous device closure of patent ductus arteriosus (PDA). STUDY DESIGN Case series. PLACE AND DURATION OF STUDY Department of Paediatric Cardiology, AFIC/NIHD, Rawalpindi, from January 2005 to December 2010. METHODOLOGY Consecutive 500 patients who underwent attempted transcatheter PDA device c...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 28  issue 3

pages  159- 160

publication date 2015-10-31

{@ msg @}

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023